On August 31, 2020 ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, reported management’s participation in the following investor conferences in September (Press release, Thermogenesis, AUG 31, 2020, View Source [SID1234564201]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

September 1-4: LD Micro 500. Chris Xu, Ph.D., Chief Executive Officer of ThermoGenesis, will present a company overview at this virtual conference on Wednesday, September 2, at 5:00 pm ET. A live webcast of the presentation will be available on the ThermoGenesis website at: View Source
An archived replay will be available for a period of 90 days after the conference.
September 14-16: H.C. Wainwright 22nd Annual Global Investment Conference. Jeff Cauble, Chief Financial Officer of ThermoGenesis, will present a company overview at this virtual conference on Tuesday, September 15, at 12:00 pm ET. A live webcast of the presentation will be available on the ThermoGenesis website at: View Source
An archive replay will be available for a period of 90 days after the conference.